Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial

被引：0
|
作者：
Yujie Jia
Xuezhu Zhang
Jianchun Yu
Jingxian Han
Tao Yu
Jiangwei Shi
Lan Zhao
Kun Nie
机构：
[1] First Teaching Hospital of Tianjin University of Traditional ChineseMedicine,
来源：
BMC Complementary and Alternative Medicine | / 17卷
关键词：
Acupuncture; Alzheimer’s disease; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial
    Jia, Yujie
    Zhang, Xuezhu
    Yu, Jianchun
    Han, Jingxian
    Yu, Tao
    Shi, Jiangwei
    Zhao, Lan
    Nie, Kun
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [2] EFFECTS OF ACUPUNCTURE ON SYMPTOMS, MICROBIOTA, AND INFLAMMATION OF PATIENTS WITH MILD TO MODERATE CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL
    Bao, Chunhui
    Liu, Huirong
    Shi, Yin
    Chen, Liming
    Wang, Di
    Li, Guona
    Jin, Xiaoming
    Zeng, Xiaoqing
    Chen, Jianhua
    Zhang, Jingzhi
    Wu, Huangan
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S205 - S205
  • [3] Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
    Feldman, H. H.
    Doody, R. S.
    Kivipelto, M.
    Sparks, D. L.
    Waters, D. D.
    Jones, R. W.
    Schwam, E.
    Schindler, R.
    Hey-Hadavi, J.
    DeMicco, D. A.
    Breazna, A.
    [J]. NEUROLOGY, 2010, 74 (12) : 956 - 964
  • [4] Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial
    Bao, Chunhui
    Wu, Luyi
    Wang, Di
    Chen, Liming
    Jin, Xiaoming
    Shi, Yin
    Li, Guona
    Zhang, Jingzhi
    Zeng, Xiaoqing
    Chen, Jianhua
    Liu, Huirong
    Wu, Huangan
    [J]. ECLINICALMEDICINE, 2022, 45
  • [5] Clinical efficacy of acupuncture combined with Western medicine in the treatment of mild to moderate Alzheimer disease: A protocol of a randomized controlled trial
    Zhou, Kangmei
    He, Jierong
    Quan, Lin
    Guo, Rong
    [J]. MEDICINE, 2022, 101 (39) : E30705
  • [6] Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease
    不详
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (09) : 2163 - 2163
  • [7] Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
    Egan, Michael F.
    Kost, James
    Tariot, Pierre N.
    Aisen, Paul S.
    Cummings, Jeffrey L.
    Vellas, Bruno
    Sur, Cyrille
    Mukai, Yuki
    Voss, Tiffini
    Furtek, Christine
    Mahoney, Erin
    Mozley, Lyn Harper
    Vandenberghe, Rik
    Mo, Yi
    Michelson, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1691 - 1703
  • [8] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: randomized, controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    [J]. ANNALS OF NEUROLOGY, 2004, 56 : S49 - S49
  • [9] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S332 - S332
  • [10] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, E. R.
    Potkin, S. G.
    Pomara, N.
    Ott, B. R.
    McDonald, S.
    Xie, Y.
    Gergel, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 187 - 187
12345